StockNews.com started coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a report published on Wednesday morning. The firm issued a hold rating on the stock. Brooklyn Immu… [+1497 chars]...
Read moreAnalysts at StockNews.com began coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Get Free Report) in a note issued to investors on Saturday. The brokerage set a “hold” rating on the stoc… [+1118 chars]...
Read moreResearch analysts at StockNews.com started coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Get Free Report) in a report released on Friday. The brokerage set a “hold” rating on the stoc… [+1118 chars]...
Read moreStockNews.com initiated coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a report issued on Thursday. The brokerage issued a hold rating on the stock. Brooklyn ImmunoThe… [+1521 chars]...
Read more